Personalized medicine in hepatitis C: Fr
✍
Hermann E. Wasmuth; Ralf Weiskirchen
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 365 KB
👁 1 views
Nonalcoholic steatosis (fatty liver) is a major cause of liver dysfunction that is associated with insulin resistance and metabolic syndrome. The cJun NH 2 -terminal kinase 1 (JNK1) signaling pathway is implicated in the pathogenesis of hepatic steatosis and drugs that target JNK1 may be useful for